MyFinsight
Home
Compare
Blog
About
Proceeds from sale of
equity method...
$100,000K
Proceeds from issuance of
long-term debt and revenue...
$48,185K
Proceeds from issuance of
convertible preferred stock
$25,000K
Proceeds from issuance of
warrants
$815K
Proceeds from exercise of
stock options
$61K
Net cash provided by
investing activities
$99,664K
Net cash provided by
financing activities
$69,175K
Canceled cashflow
$336K
Canceled cashflow
$4,886K
Net increase
(decrease) in cash and cash...
$130,914K
Canceled cashflow
$37,925K
Transfer fees related to
sale of equity method...
$336K
Issuance costs of
long-term debt and revenue...
$2,845K
Payment of initial
public offering costs
$1,785K
Issuance costs of
convertible preferred stock
-$208K
Issuance costs of
warrants
$48K
Net loss
$193,654K
Debt issuance costs
expensed upon issuance of...
-$2,845K
Loss from
discontinued operations
-$2,832K
Accounts payable
$2,715K
Stock-based compensation
$2,120K
Change in fair value
long-term debt
-$1,659K
Change in fair value of
revenue interest...
-$460K
Accounts receivable
-$269K
Prepaid research and
development
-$134K
Non-cash lease expense
$121K
Depreciation
$13K
Net cash used in
operating activities
-$37,925K
Canceled cashflow
$206,822K
Deferred revenue
-$93,525K
Gain on sale of equity
method investment
$85,380K
Deposit liability
$57,120K
Prepaid assets, other
current assets and other...
$4,427K
Accrued expenses and
other current...
-$2,741K
Change in fair value of
convertible notes
$1,315K
Operating lease liability
-$123K
Change in fair value of
contingent asset
$116K
Back
Back
Cash Flow
Apnimed, Inc. (APMD)
Apnimed, Inc. (APMD)
source: myfinsight.com